informed consent
Item
provision of informed consent
boolean
C0021430 (UMLS CUI [1])
histological breast cancer
Item
resectable breast cancer patients, with histological confirmation
boolean
C0019638 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C1514888 (UMLS CUI [1,3])
hormone therapy with anastrozole
Item
patients eligible to receive hormonal adjuvant treatment with anastrozole
boolean
C0290883 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
adjuvant chemo or radiotherapy
Item
they are allowed patients treated with adjuvant chemo or radiotherapy concurrently
boolean
C0085533 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
Tamoxifen treatment
Item
patients previously treated with tamoxifen that had to withdraw treatment due to other reason than endometrial changes are allowed
boolean
C0039286 (UMLS CUI [1,1])
C0949878 (UMLS CUI [1,2])
postmenopausal patients
Item
postmenopausal patients(aged 50 years or over/ without menses in the last months/ fsh level >40ui/l / women under 50 years with fsh levels>40ui/l).
boolean
C0232970 (UMLS CUI [1])
progesterone and/or estrogen receptors positive.
Item
women showing progesterone and/or estrogen receptors positive.
boolean
C1562029 (UMLS CUI [1])
metastatic disease
Item
patients with evidence of metastatic disease
boolean
C1282506 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
patients unsuitable to receive the medication according the anastrozole label
Item
patients unsuitable to receive the medication according the anastrozole label
boolean
C0290883 (UMLS CUI [1,1])
C3839996 (UMLS CUI [1,2])
informed consent
Item
patients not giving their informed consent
boolean
C0021430 (UMLS CUI [1])